
Join to View Full Profile
800 NE 10th StStephenson Cancer CenterOklahoma City, OK 73104
Phone+1 405-271-4022
Dr. Ibrahimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- UMass Chan - BaystateResidency, Internal Medicine, 2012 - 2015
- University of Jordan Faculty of MedicineClass of 2010
Certifications & Licensure
- OK State Medical License 2015 - 2025
- MA State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes.Olivia Davis, Carmen Lessani, Rana Kasht, Andrew Cohoon, Sami Ibrahimi
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01 - 4 citationsRecombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy.Simon Dadoun, Karolina Adam, Lisa Hensch, Theonia K Boyd, Sami Ibrahimi
Blood Advances. 2024-07-23 - 1 citationsPlain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the firs...Jeremy S Abramson, Scott R Solomon, Jon Arnason, Patrick B Johnston, Bertram Glass
Future Oncology. 2024-01-01
Journal Articles
- Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint BlockadeR Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
Press Mentions
- Study from OU Medicine Shows Why Obese Patients Respond Better to ImmunotherapyDecember 5th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: